Recurrence and 5-year survival rate in patients with borderline ovarian tumors and related factors in Kurdistan
The aim of this study was to investigate the recurrence rate and five-year survival in patients with borderline ovarian tumors and related factors. This retrospective cohort study was performed on 20 women diagnosed with a borderline ovarian tumor in Kurdistan province, Iran, between 2007 and 2019....
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2022-09-01
|
| Series: | European Journal of Translational Myology |
| Subjects: | |
| Online Access: | https://pagepressjournals.org/index.php/bam/article/view/10779 |
| _version_ | 1811258126278590464 |
|---|---|
| author | Seyedeh Reyhaneh Yousefi Sharami Fariba Farhadifar Roya Tabatabaei |
| author_facet | Seyedeh Reyhaneh Yousefi Sharami Fariba Farhadifar Roya Tabatabaei |
| author_sort | Seyedeh Reyhaneh Yousefi Sharami |
| collection | DOAJ |
| description |
The aim of this study was to investigate the recurrence rate and five-year survival in patients with borderline ovarian tumors and related factors. This retrospective cohort study was performed on 20 women diagnosed with a borderline ovarian tumor in Kurdistan province, Iran, between 2007 and 2019. Patients' records were reviewed and a researcher-made questionnaire was completed for each patient, which included demographic and clinical variables related to patient survival. The most common type of ovarian borderline tumor was the serous borderline ovarian tumor (75%). In fifty percent of the cases, cystectomy was used as th treatment. Recurrence was observed in three patients (15%), two of which were treated with cystectomy, and the other case was treated by TAH + BSO method (p = 0.64). There was no significant difference in terms of the type of surgery, history of infertility, history of taking contraceptive pills, age, age at diagnosis, and BMI between the two groups with and without recurrence (p > 0.05). The overall survival rate was 100% and none of the patients died at the end of follow-up. There was no relationship between any of the clinical and demographic variables with disease recurrence, and since all patients were alive after the end of the follow-up period. In summary, it was not possible to assess the relationship between patients' survival rate and studied variables.
|
| first_indexed | 2024-04-12T18:08:21Z |
| format | Article |
| id | doaj.art-9f56496a0db943cf827b17c99fefe388 |
| institution | Directory Open Access Journal |
| issn | 2037-7452 2037-7460 |
| language | English |
| last_indexed | 2024-04-12T18:08:21Z |
| publishDate | 2022-09-01 |
| publisher | PAGEPress Publications |
| record_format | Article |
| series | European Journal of Translational Myology |
| spelling | doaj.art-9f56496a0db943cf827b17c99fefe3882022-12-22T03:21:54ZengPAGEPress PublicationsEuropean Journal of Translational Myology2037-74522037-74602022-09-0110.4081/ejtm.2022.10779Recurrence and 5-year survival rate in patients with borderline ovarian tumors and related factors in KurdistanSeyedeh Reyhaneh Yousefi Sharami0Fariba Farhadifar1Roya Tabatabaei 2Department of Obstetrics and Gynecology, Kurdistan University of Medical Sciences, SanandajSocial Determinants of Health Research Center, Department of Gynecology, Faculty of Medicine, Kurdistan University of Medical Science, SanandajDepartment of Obstetrics and Gynecology, Kurdistan University of Medical Sciences, Sanandaj The aim of this study was to investigate the recurrence rate and five-year survival in patients with borderline ovarian tumors and related factors. This retrospective cohort study was performed on 20 women diagnosed with a borderline ovarian tumor in Kurdistan province, Iran, between 2007 and 2019. Patients' records were reviewed and a researcher-made questionnaire was completed for each patient, which included demographic and clinical variables related to patient survival. The most common type of ovarian borderline tumor was the serous borderline ovarian tumor (75%). In fifty percent of the cases, cystectomy was used as th treatment. Recurrence was observed in three patients (15%), two of which were treated with cystectomy, and the other case was treated by TAH + BSO method (p = 0.64). There was no significant difference in terms of the type of surgery, history of infertility, history of taking contraceptive pills, age, age at diagnosis, and BMI between the two groups with and without recurrence (p > 0.05). The overall survival rate was 100% and none of the patients died at the end of follow-up. There was no relationship between any of the clinical and demographic variables with disease recurrence, and since all patients were alive after the end of the follow-up period. In summary, it was not possible to assess the relationship between patients' survival rate and studied variables. https://pagepressjournals.org/index.php/bam/article/view/10779Recurrencesurvivalborderline ovarian tumorsovaryserous borderline ovarian tumor |
| spellingShingle | Seyedeh Reyhaneh Yousefi Sharami Fariba Farhadifar Roya Tabatabaei Recurrence and 5-year survival rate in patients with borderline ovarian tumors and related factors in Kurdistan European Journal of Translational Myology Recurrence survival borderline ovarian tumors ovary serous borderline ovarian tumor |
| title | Recurrence and 5-year survival rate in patients with borderline ovarian tumors and related factors in Kurdistan |
| title_full | Recurrence and 5-year survival rate in patients with borderline ovarian tumors and related factors in Kurdistan |
| title_fullStr | Recurrence and 5-year survival rate in patients with borderline ovarian tumors and related factors in Kurdistan |
| title_full_unstemmed | Recurrence and 5-year survival rate in patients with borderline ovarian tumors and related factors in Kurdistan |
| title_short | Recurrence and 5-year survival rate in patients with borderline ovarian tumors and related factors in Kurdistan |
| title_sort | recurrence and 5 year survival rate in patients with borderline ovarian tumors and related factors in kurdistan |
| topic | Recurrence survival borderline ovarian tumors ovary serous borderline ovarian tumor |
| url | https://pagepressjournals.org/index.php/bam/article/view/10779 |
| work_keys_str_mv | AT seyedehreyhanehyousefisharami recurrenceand5yearsurvivalrateinpatientswithborderlineovariantumorsandrelatedfactorsinkurdistan AT faribafarhadifar recurrenceand5yearsurvivalrateinpatientswithborderlineovariantumorsandrelatedfactorsinkurdistan AT royatabatabaei recurrenceand5yearsurvivalrateinpatientswithborderlineovariantumorsandrelatedfactorsinkurdistan |